Location: United States
Total raised: $21M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.03.2026 | Series A | $21M | - |
Mentions in press and media 5
| Date | Title | Description |
| 25.03.2026 | Innovation Surges: Biotech Secures Major Funding, E-commerce Tech Merges | Leading biotech Oryon Cell Therapies closed a $21M Series A tranche. Total funding reached $42M. The company focuses on autologous neuron replacement for Parkinson's disease. Funding will accelerate clinical trials and manufacturing scale-u... |
| 23.03.2026 | Oryon Cell Therapies Raises $21M in New Series A Tranche | Oryon Cell Therapies, a Belmont, MA-based clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson’s disease and other neurodegenerative disorders, closed a new $21M tranche of its Ser... |
| 23.03.2026 | Oryon Cell Therapies: $42 Million Raised For Autologous Neuron Replacement Therapies Targeting Parkinson’s Disease | Oryon Cell Therapies, a clinical-stage biotechnology company developing autologous neuron replacement therapies for Parkinson’s disease and other neurodegenerative disorders, announced it has emerged from stealth with total funding of $42 m... |
| 23.03.2026 | Syndigo Acquires Taggstar | Syndigo, a Chicago, Illinois-based provider of product experience management (PXM) and master data management solutions, acquired Taggstar, a London, United Kingdom-based provider of AI-powered conversion rate optimization and social proof ... |
| - | Oryon Cell Therapies | “Home - Oryon Cell Therapies” |